HLX17 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: pembrolizumab

Filter by location:

Glendale, California1 trial

A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors

Oncology Physicians Network (OPN) - Glendale

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.